A detailed history of Fmr LLC transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 2,656 shares of PHAT stock, worth $44,780. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,656
Previous 2,084 27.45%
Holding current value
$44,780
Previous $22,000 22.73%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$8.97 - $12.05 $5,130 - $6,892
572 Added 27.45%
2,656 $27,000
Q1 2024

May 13, 2024

SELL
$6.21 - $11.05 $7,756 - $13,801
-1,249 Reduced 37.47%
2,084 $22,000
Q4 2023

Feb 13, 2024

BUY
$6.99 - $10.71 $10,093 - $15,465
1,444 Added 76.44%
3,333 $30,000
Q3 2023

Nov 13, 2023

SELL
$10.26 - $15.7 $363,563 - $556,329
-35,435 Reduced 94.94%
1,889 $19,000
Q2 2023

Aug 11, 2023

BUY
$7.28 - $14.32 $266,127 - $523,481
36,556 Added 4759.9%
37,324 $534,000
Q1 2023

May 11, 2023

BUY
$6.19 - $12.36 $451 - $902
73 Added 10.5%
768 $5,000
Q4 2022

Feb 13, 2023

SELL
$9.18 - $11.53 $4,773 - $5,995
-520 Reduced 42.8%
695 $7,000
Q3 2022

Nov 10, 2022

BUY
$6.46 - $12.11 $5,407 - $10,136
837 Added 221.43%
1,215 $13,000
Q2 2022

Aug 12, 2022

SELL
$6.2 - $15.5 $651 - $1,627
-105 Reduced 21.74%
378 $3,000
Q1 2022

May 13, 2022

BUY
$11.55 - $20.06 $5,578 - $9,688
483 New
483 $7,000
Q4 2021

Feb 14, 2022

SELL
$17.83 - $33.15 $2.75 Million - $5.11 Million
-154,200 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$30.69 - $36.83 $4.73 Million - $5.68 Million
154,200 New
154,200 $4.95 Million

Others Institutions Holding PHAT

About Phathom Pharmaceuticals, Inc.


  • Ticker PHAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,175,200
  • Market Cap $660M
  • Description
  • Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...
More about PHAT
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.